TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/22/24 16:32 | 2/21/24 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Pfreundschuh Peter P. | MA | O | CFO | S | -28 | 7.46 | 0 | -4 | -2 | 176 | D | ||||||||||||||
10/5/23 16:41 | 10/3/23 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Pfreundschuh Peter P. | MA | O | CFO | S | -95 | 6.99 | 0 | -14 | -8 | 149 | D | ||||||||||||||
2/23/22 16:38 | 2/18/22 | FREQ | Frequency Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pfreundschuh Peter P. | MA | O | CFO | S.m | -11 | 3.69 | 0 | -3 | -25 | 9 | D | ||||||||||||||
2/18/22 16:14 | 2/16/22 | FREQ | Frequency Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pfreundschuh Peter P. | MA | O | CFO | S.dm | -11 | 4.31 | 0 | -3 | -18 | 12 | D | ||||||||||||||
2/16/22 16:59 | 2/14/22 | FREQ | Frequency Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pfreundschuh Peter P. | MA | O | CFO | M.d | 0 | 0.00 | 0 | 15 | 14 | D | |||||||||||||||
2/16/22 16:59 | 2/15/22 | FREQ | Frequency Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pfreundschuh Peter P. | MA | O | CFO | S.d | -6 | 4.33 | 0 | -1 | -9 | 14 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |